Results 131 to 140 of about 19,233 (248)

Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta‐Analysis

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 820-829, August 1, 2025.
ABSTRACT Transcatheter aortic valve implantation (TAVI) has changed the treatment of aortic stenosis. The Myval transcatheter heart valve (THV), a novel balloon‐expandable THV, has shown promising outcomes. Our aim is to compare the comparative safety and effectiveness of Myval THV against established THVs, such as Sapien and Evolut.
Anastasios Apostolos, Nikolaos Ktenopoulos, Maria Drakopoulou, Alfonso Ielasi, Vasileios Panoulas, Andreas Baumbach, Konstantinos Tsioufis, Patrick Serruys, Konstantinos Toutouzas   +8 more
wiley   +1 more source

Management of giant left atrial thrombus late after transcatheter mitral valve-in-ring replacement using a transcatheter aortic valve: a case report

BMC Cardiovascular Disorders
Background In symptomatic high-risk patients with severe mitral valve regurgitation (MR), who are not eligible for surgery, Transcatheter edge-to-edge repair (TEER) or transcatheter mitral valve replacement (TMVR) may be an option, especially when ...
A. Maloku, A. Hamadanchi, L. Bäz, M. Richter, S. Bargenda, S. Möbius-Winkler, P. C. Schulze, Marcus Franz   +7 more
doaj   +1 more source

Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography.

PLoS ONE, 2019
Transcatheter aortic valve implantation (TAVI) in the presence of a preexisting mitral prosthesis is challenging and its influence on the morphology of mitral prosthesis and the positioning of transcatheter heart valve (THV) is unknown.
Makoto Tanaka, Ryo Yanagisawa, Fumiaki Yashima, Takahide Arai, Masahiro Jinzaki, Hideyuki Shimizu, Keiichi Fukuda, Yusuke Watanabe, Toru Naganuma, Shinichi Shirai, Motoharu Araki, Norio Tada, Futoshi Yamanaka, Akihiro Higashimori, Kensuke Takagi, Hiroshi Ueno, Minoru Tabata, Kazuki Mizutani, Masanori Yamamoto, Kentaro Hayashida, OCEAN-TAVI investigators   +20 more
doaj   +1 more source

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 992-1001, August 1, 2025.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source

The PULSTA valve in native right ventricular outflow tract: initial experience in 3 Spanish hospitals

REC: Interventional Cardiology (English Ed.)
Introduction and objectives: Surgery for congenital heart defects with right ventricular outflow tract (RVOT) stenosis often results in significant pulmonary regurgitation, requiring pulmonary valve replacement in the long term.
Diana Salas-Mera, César Abelleira Pardeiro, Enrique José Balbacid Domingo, Adolfo Sobrino Baladrón, José Luis Zunzunegui Martínez, Fernando Sarnago Cebada, Federico Gutiérrez-Larraya Aguado   +6 more
doaj   +1 more source

Long‐Term Follow‐Up After Direct‐Flow Transcatheter Aortic Valve Implantation: A Single Center Experience

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1032-1040, August 1, 2025.
ABSTRACT Aims Valve degeneration after DirectFlow implantation poses a challenge for valve‐in‐valve procedures due to its fragile polymeric structure and embolization risk. This study analyzes long‐term follow‐up of patients who underwent TAVI with DF to understand valve degeneration tendencies.
Dan M. Prunea, Raffael Geissler, Alexandru Achim, Cosima Stark, Sadeek S. Kanoun Schnur, Brigitte Strobl, Heiko Bugger, Olev Luha, Birgit Zirngast, Albrecht Schmidt, Andreas Zirlik, Gabor G. Toth   +11 more
wiley   +1 more source

Outcomes Beyond 10 Years After Transcatheter Aortic Valve Implantation in High‐Risk Patients With Severe Aortic Valve Stenosis

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1301-1309, August 1, 2025.
ABSTRACT Background Limited data is available on long‐term outcomes and valve durability measures of transcatheter aortic valve implantation (TAVI). Aims This study sought to assess clinical and echocardiographic outcomes of high‐risk patients during the early experience of TAVI with a follow‐up period extending beyond 10 years.
Ellen Dietze, Ines Richter, Oliver Dumpies, Johannes Rotta detto Loria, Nicolas Majunke, Hans‐Josef Feistritzer, Philipp Kiefer, David Holzhey, Thilo Noack, Axel Linke, Norman Mangner, Steffen Desch, Michael Borger, Holger Thiele, Mohamed Abdel‐Wahab   +14 more
wiley   +1 more source

Bioprosthetic Valve Fracturing in Valve‐in‐Valve TAVI: Clinical and Echocardiographic Outcomes in Failing Perimount Aortic Bioprostheses—A Multicenter Registry

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1409-1420, August 1, 2025.
ABSTRACT Background Data comparing clinical and hemodynamic outcomes of bioprosthetic valve fracturing (BVF) and “standard”‐postdilatation during valve‐in‐valve transcatheter heart valve implantation (ViV‐TAVI) are lacking. The authors aimed to analyze hemodynamic and clinical outcomes of BVF compared to “standard”‐postdilatation during ViV‐TAVI ...
Hendrik Ruge, Melchior Burri, Julia Schreyer, Teodora‐Cristiana Georgescu, Derk Frank, Won‐Keun Kim, Ole de Backer, Martin Beyer, Andreas Schäfer, Chiara Fraccaro, Giuseppe Tarantini, Erion Xhepa, Michael Joner, Markus Krane, Héctor Alfonso Alvarez Covarrubias   +14 more
wiley   +1 more source

Neo Left Main Channel Creation Using Double Stenting Alongside a Sapien 3 Aortic Valve Bioprosthesis for Left Main Coronary Obstruction Following Valve-in-Valve Transcatheter Aortic Valve Replacement: A Case Report With Review of Literature

Journal of Investigative Medicine High Impact Case Reports, 2018
Transcatheter aortic valve replacement in the setting of failed surgical bioprosthesis (valve-in-valve) is a valuable option for patients with bioprosthetic aortic stenosis or regurgitation who are deemed high risk for repeat open heart surgery. Although
Apurva D. Patel MD, MPH, Thomas Haldis DO, Kais Al Balbissi MD, Timir Paul MD, PhD   +3 more
doaj   +1 more source

Arrhythmogenic mitral valve prolapse—a systematic review of ventricular arrhythmia and sudden cardiac death outcomes before and after mitral valve surgery

Journal of Arrhythmia, Volume 41, Issue 4, August 2025.
This systematic review aims to determine whether MVS reduces the incidence of VA and SCD in patients with MVP. Available studies show a likely reduction when surgery is performed in line with current guideline‐directed indications; however, a residual risk of VA and SCD remains.
James N. Cameron, Nigel Sutherland, Chee Loong Chow, Hui‐Chen Han, Matias Yudi, Rajiv Mahajan, Anand Ganesan, Avi Sabbag, Kristina H. Haugaa, Jai Raman, Prashanthan Sanders, Omar Farouque, Han S. Lim   +12 more
wiley   +1 more source